RxDoctor Payments Data

William Poulson, MD

Vascular Surgery · Kansas City, KSNPI 1164765996

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,219 of the $7,045 with a category attached, or 74.1%. It is spread thinly across 15 manufacturers, the largest accounting for just 21.8%.

$7,045in general payments, 2019–2025

Across 73 payments — averaging $96.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$2K
  • Silk Road Medical, Inc.$1K
  • Medtronic$1K
  • Penumbra, Inc.$1K
  • Endologix LLC$737
  • Inari Medical, Inc.$285
  • plus $1K from 9 others

What the payments were for

  • Travel & lodging$1,60623%
  • Food & beverage$5,21974%
  • Education$2203%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,045 in reported general payments places this provider in the 60th percentile of 22 vascular surgery providers in Kansas.

See all vascular surgery providers in Kansas

Medicare billing

Part B allowed, 2024
$113,657
Medicare patients
615
Services billed
1,006

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban11$9,167
ClopidogrelClopidogrel Bisulfate46$794
Atorvastatin Calcium49$677
Cilostazol24$653
FenofibrateFenofibrate Nanocrystallized12$1

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Kansas City

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →